Whereas a renewed national commitment to disease prevention and early detection can play a transformative role in reducing the burden of cancer in the United States and improving long-term health outcomes for all Americans;

Whereas, although overall cancer mortality rates across the United States have declined thanks to advances in early detection and treatment, persistent gaps in cancer screening exist and must be addressed to safeguard human life and public health in the Nation;

Whereas access to cancer diagnoses at earlier, more treatable stages decreases the need for intensive intervention, abating overall healthcare costs and most importantly safeguarding human life, in tandem with technological innovation and unprecedented public awareness;

Whereas, with over 2,000,000 cases of cancer diagnosed in 2025, the United States has an opportunity, through collaboration and dedication, to ensure that the life-saving benefits of modern cancer detection reach every American;

Whereas early cancer detection practices in the United States, including routine medical visits and screenings, must be advanced, including by addressing obstacles in access to care stemming from a lack of knowledge of the benefits of screening, cost concerns, and other factors in the Nation’s health care system;

Whereas research shows that up to 50 percent of cancer cases, and about 50 percent of cancer deaths, are preventable with the knowledge available to Americans today;

Whereas preventive actions, including understanding family health history, accessing risk-based screenings, avoiding tobacco and limiting alcohol use, protecting skin, increasing physical activity, maintaining a balanced diet, reducing exposure to cancer-related infections, and receiving recommended vaccinations, can significantly reduce cancer risk and improve early-detection outcomes;

Whereas gaps in screening access affect every aspect of a patient’s cancer journey, from prevention and early detection to diagnosis and successful treatment, and individuals who are disproportionately impacted or medically underserved often encounter unique challenges in pursuing care, including limited provider access, gaps in coverage, and lack of care;

Whereas improving early cancer detection necessitates ensuring access to enhanced monitoring and interventions that can reduce that risk for those with known risk factors;

Whereas many individuals today are diagnosed with cancer at later stages, leading to significantly more impactful and consequential outcomes, higher healthcare costs for all, and thousands of additional lives lost to late-stage cancers, all of which could be avoided through timely screening and intervention;

Whereas cancer does not discriminate, impacting a range of socio-economic populations and reaching people under 50 years old at rising rates;

Whereas Federal investment in early detection programs, especially those that focus on increasing screening rates in hard-to-serve populations, plays a pivotal role in tackling barriers to care that too many individuals still face;

Whereas cancer reaches even those with broad public visibility in society, highlighting the need for elevated awareness and action;

Whereas Federal agencies play an essential role in shaping the regulatory and administrative landscape for cancer screenings and early detection in the evaluation of technologies, providing streamlined approval of cancer products and access to novel medications and treatments;

Whereas dedicated stakeholder advocates, medical professionals, researchers, and policymakers working together can ensure that early detection of cancer saves lives and reduces long-standing health consequences; and

Whereas April has been recognized as Cancer Prevention and Early Detection Month: Now, therefore, be it